Aegerion Pharmaceuticals, Inc. is a startup based in the United States.
Aegerion Pharmaceuticals, Inc. is a startup based in the United States.
Aegerion Pharmaceuticals is a biopharmaceutical company that develops and commercializes therapies for rare and ultra-rare lipid disorders, with a therapeutic focus on conditions such as homozygous familial hypercholesterolemia (HoFH).
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.